» Authors » Kefan Cai

Kefan Cai

Explore the profile of Kefan Cai including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 17
Citations 20
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Jia Y, Cai K, Qiao N, Liu F, Wu W, Ru S, et al.
J Clin Med . 2023 Oct; 12(20). PMID: 37892690
Objective: The enlarged endonasal approach (EEA) has emerged as the preferred surgical procedure for removing craniopharyngiomas, due to its advantages of direct visualization and reduction of blind corners. However, owing...
12.
Jin L, Cai K, Wu W, Xiao Y, Qiao N, Liu F, et al.
Front Endocrinol (Lausanne) . 2023 Oct; 14:1167776. PMID: 37854185
Objective: To investigate the clinical and pathological factors associated with preoperative hypothalamus invasion and postoperative outcomes of adamantinomatous craniopharyngiomas (ACPs) after the expanded endonasal approach (EEA) resection. Methods: Ninety-three specimens...
13.
Li X, Jiang Z, Zhang C, Cai K, Wang H, Pan W, et al.
BMC Plant Biol . 2023 Oct; 23(1):484. PMID: 37817059
Background: Light-harvesting chlorophyll a/b b evelopment of higher plants and in response to abiotic stress. Previous works has demonstrated that that Lhcb genes were involved in the phytochrome regulation and...
14.
Xiao Y, Wu W, Cai K, Jin L, Jia Y, Qiao N, et al.
Biomolecules . 2023 Jul; 13(7). PMID: 37509115
Craniopharyngioma (CP) is a benign tumor with a high rate of obesity and frequent recurrence. Moreover, the role of leptin/leptin receptors axis in obesity and the prognosis of CP is...
15.
Qiao N, Li C, Liu F, Ru S, Cai K, Jia Y, et al.
J Neurosurg . 2023 Jun; 140(1):47-58. PMID: 37382333
Objective: Over the last decade, the extended endoscopic endonasal approach (EEEA) has evolved as a credible surgical alternative for removing craniopharyngiomas. However, postoperative cerebrospinal fluid (CSF) leak remains one of...
16.
Li Y, Xiao Y, Wu W, Jin L, Jia Y, Cai K, et al.
J Clin Med . 2023 Feb; 12(4). PMID: 36836112
Craniopharyngioma (CP) is a histologically benign tumor with high mortality and morbidity. Although surgical treatment is essential in managing CP, the best surgical approach is debated. A retrospective cohort of...
17.
Jia Y, Ma L, Cai K, Zhang B, Wu W, Xiao Y, et al.
Front Immunol . 2022 Nov; 13:995655. PMID: 36389809
Papillary craniopharyngiomas (PCPs) are biologically benign but clinically aggressive lesions hence affect the quality of life. The expression of inflammatory mediators and regulation of the immune microenvironment in PCPs have...
18.
Jia Y, Wu W, Xiao Y, Cai K, Gui S, Li Q, et al.
J Oncol . 2022 Oct; 2022:6891655. PMID: 36268277
Background: Craniopharyngioma (CP) is a benign slow-growing tumor. It tends to affect children, and the number of patients is on rise. Considering the high morbidity and mortality of CP, it...
19.
Cao L, Wu W, Kang J, Cai K, Li C, Liu C, et al.
Neurosurg Rev . 2022 May; 45(4):1-13. PMID: 35597836
Intrinsic third ventricular craniopharyngiomas (IVCs) are usually considered as a contraindication of endoscopic endonasal approach (EEA). The aim of this study is to evaluate the safety and feasibility of EEA...